NDC 70954-301 – Mesalamine
Mesalamine 4 g/60mL · Suspension · Rectal
Product NDC70954-301
Product details
- Brand name
- Mesalamine
- Generic name
- Mesalamine
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- Suspension
- Route
- Rectal
- Marketing category
- ANDA · ANDA215269
- Marketed since
- May 14, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Aminosalicylate
Active ingredients
- Mesalamine 4 g/60mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70954-301-20 | 7 BOTTLE in 1 CARTON (70954-301-20) / 60 mL in 1 BOTTLE (70954-301-10) | May 14, 2026 |
Other Mesalamine products
- 72162-2302 Mesalamine 4 g/60mL · Suspension · Bryant Ranch Prepack
- 21922-045 Mesalamine 4 g/60mL · Suspension · Encube Ethicals, Inc.
- 84725-002 Mesalamine 4 g/60mL · Suspension · KLM Laboratories Private Limited
- 0472-1915 Mesalamine 1000 mg/1 · Suppository · Actavis Pharma, Inc.
- 0591-2245 Mesalamine 1.2 g/1 · Tablet, Delayed Release · Actavis Pharma, Inc.
- 62332-724 Mesalamine .375 g/1 · Capsule, Extended Release · Alembic Pharmaceuticals Inc.
- 46708-724 Mesalamine .375 g/1 · Capsule, Extended Release · Alembic Pharmaceuticals Limited
- 60687-650 Mesalamine .375 g/1 · Capsule, Extended Release · American Health Packaging
- 60687-408 Mesalamine 800 mg/1 · Tablet, Delayed Release · American Health Packaging
- 60687-556 Mesalamine 400 mg/1 · Capsule, Delayed Release · American Health Packaging
- 60687-397 Mesalamine 1.2 g/1 · Tablet, Delayed Release · American Health Packaging
- 65162-360 Mesalamine 800 mg/1 · Tablet, Delayed Release · Amneal Pharmaceuticals LLC